HALO
Price
$74.01
Change
+$3.67 (+5.22%)
Updated
Nov 24, 04:59 PM (EDT)
Capitalization
8.7B
92 days until earnings call
Intraday BUY SELL Signals
LGVN
Price
$0.60
Change
-$0.00 (-0.00%)
Updated
Nov 21 closing price
Capitalization
12.81M
Intraday BUY SELL Signals
Interact to see
Advertisement

HALO vs LGVN

Header iconHALO vs LGVN Comparison
Open Charts HALO vs LGVNBanner chart's image
Halozyme Therapeutics
Price$74.01
Change+$3.67 (+5.22%)
Volume$408.6K
Capitalization8.7B
Longeveron
Price$0.60
Change-$0.00 (-0.00%)
Volume$487.82K
Capitalization12.81M
HALO vs LGVN Comparison Chart in %
HALO
Daily Signal:
Gain/Loss:
LGVN
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
HALO vs. LGVN commentary
Nov 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HALO is a Hold and LGVN is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 25, 2025
Stock price -- (HALO: $70.34 vs. LGVN: $0.60)
Brand notoriety: HALO and LGVN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: HALO: 97% vs. LGVN: 109%
Market capitalization -- HALO: $8.7B vs. LGVN: $12.81M
HALO [@Biotechnology] is valued at $8.7B. LGVN’s [@Biotechnology] market capitalization is $12.81M. The market cap for tickers in the [@Biotechnology] industry ranges from $107.58B to $0. The average market capitalization across the [@Biotechnology] industry is $2.13B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

HALO’s FA Score shows that 1 FA rating(s) are green whileLGVN’s FA Score has 0 green FA rating(s).

  • HALO’s FA Score: 1 green, 4 red.
  • LGVN’s FA Score: 0 green, 5 red.
According to our system of comparison, HALO is a better buy in the long-term than LGVN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

HALO’s TA Score shows that 6 TA indicator(s) are bullish while LGVN’s TA Score has 2 bullish TA indicator(s).

  • HALO’s TA Score: 6 bullish, 4 bearish.
  • LGVN’s TA Score: 2 bullish, 6 bearish.
According to our system of comparison, HALO is a better buy in the short-term than LGVN.

Price Growth

HALO (@Biotechnology) experienced а +0.44% price change this week, while LGVN (@Biotechnology) price change was -11.98% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.35%. For the same industry, the average monthly price growth was -2.85%, and the average quarterly price growth was +69.23%.

Reported Earning Dates

HALO is expected to report earnings on Feb 24, 2026.

Industries' Descriptions

@Biotechnology (+1.35% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
HALO($8.7B) has a higher market cap than LGVN($12.8M). HALO has higher P/E ratio than LGVN: HALO (15.61) vs LGVN (2.95). HALO YTD gains are higher at: 47.124 vs. LGVN (-65.318). HALO has higher annual earnings (EBITDA): 792M vs. LGVN (-18.35M). HALO has more cash in the bank: 548M vs. LGVN (10.3M). LGVN has less debt than HALO: LGVN (1.14M) vs HALO (1.51B). HALO has higher revenues than LGVN: HALO (1.18B) vs LGVN (2.07M).
HALOLGVNHALO / LGVN
Capitalization8.7B12.8M67,984%
EBITDA792M-18.35M-4,316%
Gain YTD47.124-65.318-72%
P/E Ratio15.612.95530%
Revenue1.18B2.07M56,874%
Total Cash548M10.3M5,320%
Total Debt1.51B1.14M132,368%
FUNDAMENTALS RATINGS
HALO: Fundamental Ratings
HALO
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
74
Overvalued
PROFIT vs RISK RATING
1..100
34
SMR RATING
1..100
11
PRICE GROWTH RATING
1..100
43
P/E GROWTH RATING
1..100
42
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
HALOLGVN
RSI
ODDS (%)
Bearish Trend 4 days ago
60%
Bullish Trend 4 days ago
83%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
60%
Bullish Trend 4 days ago
90%
Momentum
ODDS (%)
Bullish Trend 4 days ago
67%
Bearish Trend 4 days ago
90%
MACD
ODDS (%)
Bullish Trend 4 days ago
74%
Bearish Trend 4 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
76%
Bearish Trend 4 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
74%
Bearish Trend 4 days ago
90%
Advances
ODDS (%)
Bullish Trend 12 days ago
80%
N/A
Declines
ODDS (%)
Bearish Trend 15 days ago
68%
Bearish Trend 4 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
65%
N/A
Aroon
ODDS (%)
Bullish Trend 4 days ago
72%
Bearish Trend 4 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
HALO
Daily Signal:
Gain/Loss:
LGVN
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ANORX19.510.49
+2.58%
American Century Small Cap Growth R
VESAX19.670.41
+2.13%
VELA Small Cap A
PKAPX14.980.29
+1.97%
PIMCO RAE US I-2
BAFGX17.590.21
+1.21%
Brown Advisory Growth Equity Inst
NZDEUR0.490.00
+0.13%
New Zealand Dollar - Euro

LGVN and

Correlation & Price change

A.I.dvisor indicates that over the last year, LGVN has been loosely correlated with BIVI. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if LGVN jumps, then BIVI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LGVN
1D Price
Change %
LGVN100%
-0.56%
BIVI - LGVN
50%
Loosely correlated
+1.97%
HRTX - LGVN
43%
Loosely correlated
+0.47%
RXRX - LGVN
39%
Loosely correlated
+8.31%
QURE - LGVN
37%
Loosely correlated
-0.32%
SNGX - LGVN
36%
Loosely correlated
+11.02%
More